Irradiated membrane for cell expansion

US10974201B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10974201-B2
Application numberUS-200913120375-A
CountryUS
Kind codeB2
Filing dateSep 23, 2009
Priority dateSep 25, 2008
Publication dateApr 13, 2021
Grant dateApr 13, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A membrane for cultivating adherent or suspension cells, in particular adherent cells. The membrane permits adhesion and proliferation of the cells due to the irradiation of the wet or dry membrane with gamma or beta rays or an electron beam in a dose of from 12.5 to 175 kGy in the presence of oxygen. The resulting membrane may be used without any pre-treatment with surface-modifying substances. A method for preparing such an irradiated membrane for cultivating adherent or suspension cells. Methods of using such a membrane for cultivating adherent or suspension cells.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cell culturing device comprising a) a membrane comprising i) a component selected from the group consisting of a polysulfone, polyethersulfone, a polyarylethersulfone, and combinations thereof, and ii) a polyvinylpyrrolidone, wherein the membrane has been irradiated with at least one of gamma-rays or beta-rays in a dose of from 70 to 175 kGy in the presence of oxygen at a concentration of 4 to 100 vol %, and b) adherent cells. 2. A device for the extracorporeal treatment of body fluids, the device comprising a) adherent cells and b) an irradiated membrane including at least one of a lumen surface and an outer surface, the membrane comprising i) a component selected from the group consisting of a polysulfone, polyethersulfone, a polyarylethersulfone, and combinations thereof, and ii) a polyvinylpyrrolidone, wherein the adherent cells form a confluent layer on the lumen surface or outer surface of the membrane, and wherein the membrane has been irradiated with at least one of gamma-rays or beta-rays in a dose of from 70 to 175 kGy in the presence of oxygen at a concentration of 4 to 100 vol %. 3. The cell culturing device of claim 1 , wherein the adherent cells are selected from the group consisting of stem cells, embryonic stem cells, adult stem cells, mesenchymal stem cells (MSC), hematopoietic stem cells, cord blood cells, neural stem cells, smooth muscle cells, skin cells, nerve cells, neuroglia cells, endothelial cells, epithelial cells, fibroblasts, hepatocytes, endothelial cells, muscle cells, and chondrocytes. 4. The cell culturing device of claim 1 , wherein the adherent cells are selected from the group consisting of mesenchymal stem cells (MSC), fibroblasts, epithelial cells, and hepatocytes. 5. The device of claim 2 , wherein the adherent cells are selected from the group consisting of stem cells, embryonic stem cells, adult stem cells, mesenchymal stem cells (MSC), hematopoietic stem cells, cord blood cells, neural stem cells, smooth muscle cells, skin cells, nerve cells, neuroglia cells, endothelial cells, epithelial cells, fibroblasts, hepatocytes, endothelial cells, muscle cells, and chondrocytes. 6. The device of claim 2 , wherein the adherent cells are selected from the group consisting of mesenchymal stem cells (MSC), fibroblasts, epithelial cells, and hepatocytes. 7. The cell culturing device of claim 1 , wherein the membrane further comprises a polyurethane. 8. The cell culturing device of claim 1 , wherein the membrane further comprises a polyamide. 9. The cell culturing device of claim 1 , wherein the membrane is a hollow fiber membrane. 10. The cell culturing device of claim 1 , wherein the membrane is a flat sheet membrane. 11. The cell culturing device of claim 1 , wherein the membrane has been irradiated in the presence of oxygen at a concentration of 4 to 30 vol %. 12. The cell culturing device of claim 1 , wherein the polyvinylpyrrolidone comprises a blend of at least two polyvinylpyrrolidone (PVP) homopolymers, wherein the first PVP homopolymer is a low molecular weight PVP comprising an average relative molecular weight of from about 10,000 g/mol to 100,000 g/mol and wherein the second PVP homopolymer is a high molecular weight PVP comprising an average relative molecular weight of from about 500,000 g/mol to 2,000,000 g/mol. 13. The cell culturing device of claim 9 , wherein the hollow fiber membrane comprises an interior of the hollow fiber membrane and an exterior of the hollow fiber membrane, and wherein the adherent cells are present on the interior of the hollow fiber membrane and the exterior of the hollow fiber membrane. 14. The device of claim 2 , wherein the membrane further comprises a polyurethane. 15. The device of claim 2 , wherein the membrane further comprises a polyamide. 16. The device of claim 2 , wherein the membrane is a hollow fiber membrane. 17. The device of claim 2 , wherein the membrane is a flat sheet membrane. 18. The device of claim 2 , wherein the membrane has been irradiated in the presence of oxygen at a concentration of 4 to 30 vol %. 19. The device of claim 2 , wherein the polyvinylpyrrolidone comprises a blend of at least two polyvinylpyrrolidone (PVP) homopolymers, wherein the first PVP homopolymer is a low molecular weight PVP comprising an average relative molecular weight of from about 10,000 g/mol to 100,000 g/mol and wherein the second PVP homopolymer is a high molecular weight PVP comprising an average relative molecular weight of from about 500,000 g/mol to 2,000,000 g/mol. 20. The device of claim 16 , wherein the hollow fiber membrane comprises an interior of the hollow fiber membrane and an exterior of the hollow fiber membrane, and wherein the adherent cells are present on the interior of the hollow fiber membrane and the exterior of the hollow fiber membrane.

Assignees

Inventors

Classifications

  • Filtration · CPC title

  • B01D67/009Primary

    with wave-energy, particle-radiation or plasma · CPC title

  • Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00) · CPC title

  • General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title

  • Fibronectin; Laminin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10974201B2 cover?
A membrane for cultivating adherent or suspension cells, in particular adherent cells. The membrane permits adhesion and proliferation of the cells due to the irradiation of the wet or dry membrane with gamma or beta rays or an electron beam in a dose of from 12.5 to 175 kGy in the presence of oxygen. The resulting membrane may be used without any pre-treatment with surface-modifying substances…
Who is the assignee on this patent?
Krause Bernd, Neubauer Markus, Loercher Joachim, and 1 more
What technology area does this patent fall under?
Primary CPC classification B01D67/009. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).